The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Open accessAbstract
BACKGROUND: Calcific aortic stenosis has many characteristics in common with atherosclerosis, including hypercholesterolemia. We hypothesized that intensive lipid-lowering therapy would halt the progression of calcific aortic stenosis or induce its regression. METHODS: In this double-blind, placebo-controlled trial, patients with calcific aortic stenosis were randomly assigned to receive either 80 mg of atorvastatin daily or a matched placebo. Aortic-valve stenosis and calcification were assessed with the use of Doppler echocardiography and helical computed tomography, respectively. The primary end points were change in aortic-jet velocity and aortic-valve calcium score. RESULTS: Seventy-seven patients were assigned to atorvastatin and 78 to placebo, with a median follow-up of 25 months (range, 7 to 36). Serum low-density lipoprotein cholesterol concentrations remained at 130+/-30 mg per deciliter in the placebo group and fell to 63+/-23 mg per deciliter in the atorvastatin group (P<0.001). Increases in aortic-jet velocity were 0.199+/-0.210 m per second per year in the atorvastatin group and 0.203+/-0.208 m per second per year in the placebo group (P=0.95; adjusted mean difference, 0.002; 95 percent confidence interval, -0.066 to 0.070 m per second per year). Progression in valvular calcification was 22.3+/-21.0 percent per year in the atorvastatin group, and 21.7+/-19.8 percent per year in the placebo group (P=0.93; ratio of post-treatment aortic-valve calcium score, 0.998; 95 percent confidence interval, 0.947 to 1.050). CONCLUSIONS: Intensive lipid-lowering therapy does not halt the progression of calcific aortic stenosis or induce its regression. This study cannot exclude a small reduction in the rate of disease progression or a significant reduction in major clinical end points. Long-term, large-scale, randomized, controlled trials are needed to establish the role of statin therapy in patients with calcific aortic stenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“several randomized trials showed no effect of statins on haemodynamic progression or AS-related clinical events152–154.”
From Calcific aortic stenosis (2016) · cites this paper as [152]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, three randomized clinical trials (RCTs) failed to demonstrate any significant benefit of LDL lowering with statins on the progression of AS152–154.”
From Calcific aortic stenosis (2016) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“Several intervention studies have been performed to test the hypothesis that lipid lowering with statin medications would slow the progression of AS, however the results were generally disappointing152–154.”
From Calcific aortic stenosis (2016) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“randomized controlled trials (RCTs) failed to demonstrate any benefit of statin therapy on retard disease progression6–8.”
From Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study (2025) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Several clinical trials evaluating statin therapy in mild to moderate AS failed to demonstrate efficacy in lipid lowering as a strategy to mitigate adverse events in the disease39–41.”
From Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction (2026) · cites this paper as [39]
In the citing paper
“lipid-lowering therapy to delay progression of AS has been evaluated in 3 randomized controlled trials; however, all trials reported no significant benefit.[12][13][14]”
From Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis (2024) · cites this paper as [12]
In the citing paper
“The SALTIRE (Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression) and ASTRONOMER (Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin) trials, which evaluated statin efficacy in AS, were constrained by small sample sizes (n=150 and n=269), 12,13 limited median follow-up periods (25 and 42 months), and a focus on advanced AS stages (mean peak velocity, 3.”
From Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis (2024) · cites this paper as [12]
In the citing paper
“All of the clinical trials aimed to halt the progression of established AS.”
From Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis (2024) · cites this paper as [12]
In the citing paper
“Second, we observed similar associations with AVR as a strict procedural outcome, which is particularly meaningful in the context of previous neutral clinical trials of lipid-lowering therapies that used AVR as the study end point.[12][13][14]”
From Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis (2024) · cites this paper as [12]
In the citing paper
“Secondary prevention therapy with statins reduces the risk of recurrent stroke (by 12% per mmol/L reduction in LDL cholesterol), MI, and vascular death [459,460].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [459]
In the citing paper
“Notably, ischaemic events were reduced by 21% in the SEAS trial.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [377]
In the citing paper
“Suggestions for an association between aortic stenosis, LDL-C and Lp(a), as well as between cholesterol and increased risk for calcification of bioprosthetic valves, were matched with early observational noncontrolled trials that showed beneficial effects of aggressive lipid lowering in slowing the progression of aortic stenosis. However, this was not confirmed in RCTs. 243,377,378”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [377]
In the citing paper
“Notably, ischaemic events were reduced by 21% in the SEAS trial.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [377]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Zoghbi, W. A., Enriquez-Sarano, M. L., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quiñones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,041
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Clinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Applied Mixed Models in Medicine
Brown, H., & Presco, R. (2000) · Technometrics · doi:10.1080/00401706.2000.10485742 · Cited by 1,699
Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis
Rosenhek, R., Binder, T. M., Porenta, G., Lang, I. M., Christ, G., SCHEMPER, M., Maurer, G., & Baumgartner, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430903 · Cited by 1,332
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O’Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly
Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J., & Siscovick, D. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410302 · Cited by 1,281
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,000
Liu, F., & Cai, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1583267 · Cited by 10
Mohammadnia, N., Vestjens, L. T. W., Craig, N. J., Tijssen, J. G. P., Knol, R. J. J., Lazarenko, S. V., Duffels, M. G. J., Focks, J. J., Hemels, M. E. W., Oving, I., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.07.010 · Cited by 10
Simonen, P. P., Lommi, J., Hallikainen, M., Suihko, S., Werkkala, K., Kupari, M. M., Kovanen, P. T., & Gylling, H. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.001 · Cited by 10
Short‐term LPS induces aortic valve thickening in ApoE*3Leiden mice
van Broekhoven, A., Krijnen, P. A. J., Fuijkschot, W. W., Morrison, M. C., Zethof, I. P. A., van Wieringen, W. N., Smulders, Y. M., Niessen, H. W. M., & Vonk, A. B. A. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13121 · Cited by 10
Khurrami, L., Møller, J. E., Dahl, J. S., Carter‐Storch, R., Christensen, N. L., Pareek, M., Lindholt, J. S., & Diederichsen, A. C. P. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-02012-2 · Cited by 10
The current landscape of lipoprotein(a) in calcific aortic valvular disease
Hsieh, G., Rizk, T., Berman, A. N., Biery, D. W., & Blankstein, R. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000901 · Cited by 10
Quarta, S., Santarpino, G., Carluccio, M. A., Calabriso, N., Maffia, M., Siculella, L., Damiano, F., Madonna, R., & Massaro, M. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107210 · Cited by 10
Zhou, Y., Yuan, Z., Wang, M., Zhang, Z., Tan, C., Yu, J., Bi, Y., Liao, X., Zhou, X., Sheikh, M. S. A., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10090386 · Cited by 11
Gil-Dones, F., Martín-Rojas, T., Lopez-Almodovar, L. F., Juárez-Tosina, R., de la Cuesta, F., Álvarez‐Llamas, G., Alonso‐Orgaz, S., Vivanco, F., Padial, L. R., & Barderas, M. G. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70008-7 · Cited by 10
Current State of Symptomatic Aortic Valve Stenosis in the Japanese Elderly
Ohno, M., Hashimoto, Y., Suzuki, M., Matsumura, A., & Isobe, M. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0012 · Cited by 10
What Can We Learn About Valvular Heart Disease From PET/CT?
Jenkins, W. S. A., Chin, C., Rudd, J. H. F., Newby, D. E., & Dweck, M. R. (2013) · Future Cardiology · doi:10.2217/fca.13.47 · Cited by 10
Self-citationLee, J. C., Zhao, X.-Q., & Otto, C. M. (2005) · Journal of Echocardiography · doi:10.2303/jecho.3.51 · Cited by 10
Spitzer, E., Ren, B., Kroon, H. G., Gils, L. V., Manintveld, O. C., Daemen, J., Zijlstra, F., de Jaegere, P. P. T., Geleijnse, M. L., & Mieghem, N. M. V. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00111 · Cited by 10
Fletcher, A. J., & Dweck, M. R. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02411-x · Cited by 10
Aortic Valve Calcification Is Associated with Future Cognitive Impairment
Chung, H. E., Chen, J. W., Ghosalkar, D. S., Christensen, J. L., Chu, A., Mantsounga, C., Neverson, J., Soares, C., Shah, N. R., Wu, W., et al. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200253 · Cited by 10
How to Manage Mitral Stenosis Due to Mitral Annular Calcification
Cheng, R. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01567-3 · Cited by 10
Organ Culture Model of Aortic Valve Calcification
Chester, A. H., Sarathchandra, P., McCormack, A. M., & Yacoub, M. H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.734692 · Cited by 10
Towards Personalized Therapy of Aortic Stenosis
Mazur, P. K., Kopytek, M., Ząbczyk, M., Undas, A., & Natorska, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121292 · Cited by 10
da Rosa, E. M., Sant'Anna, J. R. M., Oppermann, L. P., & Castro, I. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000200016 · Cited by 10
Tsuchida, M., Kawashiri, M., Tada, H., Takata, M., Nohara, A., Ino, H., Inazu, A., Kobayashi, J., Koizumi, J., Mabuchi, H., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0164 · Cited by 10
Influence of Aortic Valve Calcium on Outcome in Patients Undergoing Peripheral Vascular Surgery
Valentijn, T. M., Hoeks, S. E., Bakker, E. J., Voûte, M. T., Chonchol, M., van de Luijtgaarden, K. M., Verhagen, H. J. M., & Stolker, R. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.062 · Cited by 10
Arrieta, V., Sádaba, R., Álvarez, V., Rodríguez, J. A., & López‐Andrés, N. (2019) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0643 · Cited by 10
New understanding about calcific aortic stenosis and opportunities for pharmacologic intervention
Moura, L. M., Maganti, K., Puthumana, J. J., Rocha‐Gonçalves, F., & Rajamannan, N. M. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282f0dae6 · Cited by 11
Griffin, B. P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.002 · Cited by 10
Endothelial factors in the pathogenesis of aortic valve stenosis
Peltonen, T. (2008) · Cited by 10
Kany, S., Rämö, J. T., Playford, D. A., Strange, G. A., Hou, C. R., Jurgens, S. J., Nauffal, V., Cunningham, J. W., Lau, E. S., Butte, A. J., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.01.035 · Cited by 10
Myasoedova, V. A., Franchi, M., Giorgi, D. D., Bonomi, A., Valerio, V., Pirola, S., Andreani, N., Rusconi, V., Bertolini, F., Massaiu, I., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107737 · Cited by 9
Oikonomou, E. K., Craig, N. J., Holste, G., Shankar, S. V., White, A. C., Mahendran, M., Newby, D. E., Dweck, M. R., & Khera, R. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.125.018353 · Cited by 9
Self-citationYao, Q., Song, R., Ao, L., Zhan, Q., Cleveland, J. C., Yu, X., Fullerton, D. A., & Meng, X. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.06.021 · Cited by 10
Progress in Perioperative Medicine: Focus on Statins
Singh, N., Patel, P. A., Wyckoff, T., & Augoustides, J. G. (2010) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2010.06.015 · Cited by 9
Arterial hypertension and diastolic blood pressure associate with aortic stenosis
Ljungberg, J., Johansson, B. H., Engström, K. G., Norberg, M., Bergdahl, I. A., & Söderberg, S. (2019) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2019.1605094 · Cited by 9
Ali, A. M., Wasim, D., Løland, K. H., Rotevatn, S., Bleie, Ø., & Saeed, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-039961 · Cited by 9
Long-term Prognosis of Mild to Moderate Aortic Stenosis and Coronary Artery Disease
Lee, W., Choi, W., Kang, S., Hwang, I., Choi, H., Yoon, Y. E., & Cho, G. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e47 · Cited by 9
Delgado‐Lista, J., Mostaza, J. M., Arrobas-Velilla, T., Blanco‐Vaca, F., Masana, L., Pedro‐Botet, J., Pérez‐Martínez, P., Civeira, F., Cuende, J. I., Gómez-Barrado, J. J., et al. (2024) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2024.07.008 · Cited by 9
Chong-Nguyen, C., Yılmaz, B., Coles, B., Sokol, H., Macpherson, A. J., Siepe, M., Reineke, D., Mosbahi, S., Tomii, D., Nakase, M., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.14381 · Cited by 9
Price, L., Sniderman, A. D., Omerglu, A., & Lachapelle, K. J. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70751-1 · Cited by 9
Imaging of Inflammation and Calcification in Aortic Stenosis
Dweck, M. R., Joshi, N. V., Rudd, J. H. F., & Newby, D. E. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0320-8 · Cited by 9
Self-citationJassal, D. S., Bhagirath, K. M., Karlstedt, E., Zeglinski, M. R., Dumesnil, J. G., Teo, K. K., Tam, J. W., & Chan, K. L. (2011) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-9-5 · Cited by 9
Aortic stenosis: new pathophysiological mechanisms and their therapeutic implications
Dimitrow, P. P. (2014) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2562 · Cited by 9
Calcific aortic stenosis: known facts and promising studies
Karpova, N. Y., Rashid, M. A., Казакова, Т. В., Chipigina, N. S., & Zudilina, A. E. (2020) · The Clinician · doi:10.17650/1818-8338-2020-14-1-2-34-41 · Cited by 9
Xie, K., Zeng, J., Wen, L., Peng, X., Lin, Z., Xian, G., Guo, Y., Yang, X., Li, P., Xu, D., et al. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.11.017 · Cited by 10
Aortic valvular heart disease: is there a place for angiotensin-converting-enzyme inhibitors?
Elder, D. H. J., McAlpine-Scott, V., Choy, A. M., Struthers, A. D., & Lang, C. C. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.143 · Cited by 9
Diagnosis and management of patients with asymptomatic severe aortic stenosis
Katayama, M. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i2.192 · Cited by 9
Antonini‐Canterin, F., Corrado, G., Faggiano, P. M., Popescu, B. A., Carerj, S., Carrubba, S. L., Zuppiroli, A., & Nicolosi, G. L. (2006) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000234763.76132.0d · Cited by 9
Otto, C. M. (2007) · Cardiology in Review · doi:10.1097/crd.0b013e318156a798 · Cited by 9
Aortic valve stenosis: the long and winding road
Kronenberg, F. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1069 · Cited by 9
Navigating the Landscape of Translational Medicine of Calcific Aortic Valve Disease
Qian, X., Xu, L., Geng, B., Li, F., & Dong, N. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.01.014 · Cited by 10
Lipoprotein(a) in clinical practice: Risk stratification and therapeutic strategies
Nasrallah, N., Atallah, Harb, T., Gerstenblith, G., & Leucker, T. M. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70127 · Cited by 8
Enfermedad de la válvula aórtica calcificada. Su asociación con la arteriosclerosis
Toro, R., Mangas, A., & Gómez, F. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2010.02.019 · Cited by 8
Girard, A. S., Gaillard, E., Puri, R., Capoulade, R., Chan, K. L., Paulin, A., Manikpurage, H. D., Dumesnil, J. G., Tam, J. W., Teo, K. K., et al. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead032 · Cited by 8
Valvular Prostaglandins Are Elevated in Severe Human Aortic Valve Stenosis
Cayer, L. G. J., Surendran, A., Karakach, T. K., Aukema, H. M., & Ravandi, A. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320001 · Cited by 8
Kontogeorgos, S., Rosengren, A., Sandström, T. Z., Fu, M. L. X., Lindgren, M., Basic, C., Svanvik, T., Djekic, D., & Thunström, E. Ö. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034891 · Cited by 8
Capoulade, R., Chan, K. L., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Yang, X., Witztum, J. L., Arsenault, B. J., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.013 · Cited by 8
The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease
Hanna, L., Armour, C. H., Xu, X. Y., & Gibbs, R. G. J. (2022) · Biomedicines · doi:10.3390/biomedicines10061317 · Cited by 10
Wen, H., Huang, R., Xu, X., Xiong, Z., Liu, M., Guo, Y., Zhuang, X., & Liao, X. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae078 · Cited by 8
Current imaging modalities for atherosclerosis
Kataoka, Y., Uno, K., Puri, R., & Nicholls, S. J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.28 · Cited by 8
Asymptomatic Adult Patients With Aortic Stenosis: Should They Ever Have Aortic Valve Replacement?
Cheitlin, M. D. (2005) · The American Heart Hospital Journal · doi:10.1111/j.1541-9215.2005.04258.x · Cited by 8
Efficacy and safety of ezetimibe plus atorvastatin therapy
Foody, J. M., Toth, P. P., Tershakovec, A. M., Musliner, T., Tomassini, J. E., Lowe, R. S., Neff, D., & Davis, H. R. (2014) · Clinical Lipidology · doi:10.2217/clp.14.36 · Cited by 8
Is there a role of statins in the prevention of aortic biological prostheses degeneration
Antonini‐Canterin, F., Zuppiroli, A., Baldessin, F., Popescu, B. A., & Nicolosi, G. L. (2006) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-4-26 · Cited by 8
Reassessment of statins to retard the progression of aortic stenosis
Rajamannan, N. M. (2007) · Current Cardiology Reports · doi:10.1007/bf02938335 · Cited by 8
Zhao, Y. X., Nicoll, R., He, Y., & Henein, M. Y. (2016) · Data in Brief · doi:10.1016/j.dib.2016.02.045 · Cited by 8
Lipid-Lowering Therapy in Calcific Aortic Stenosis
Chan, K. L., & Teo, K. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051838 · Cited by 8
Yu, B., Kapur, H., Hamid, Q. A., Khan, K., Thanassoulis, G., Cecere, R., de Varennes, B., Genest, J. J., & Schwertani, A. G. (2018) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000181 · Cited by 7
Managing complications of hypertension in aortic valve stenosis patients
Saeed, S., & Gerdts, E. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1535899 · Cited by 7
Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling
Kim, D., Chae, D., Shim, C. Y., Cho, I., Hong, G., Park, K., & Ha, J.-W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091302 · Cited by 7
Kurasawa, S., Hishida, M., Imaizumi, T., Okazaki, M., Nishibori, N., Kondo, T., Kasuga, H., & Maruyama, S. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.06.910 · Cited by 7
Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities
Pinto, G., & Fragasso, G. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2118576 · Cited by 8
Chong, T., Lan, N. S. R., Courtney, W., He, A., Strange, G. A., Playford, D. A., Dwivedi, G., Hillis, G. S., & Ihdayhid, A. R. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000528 · Cited by 7
Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
Seo, J., Kim, K. H., Chun, K. J., Lee, B., Cho, B. R., & Ryu, D. R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1171703 · Cited by 7
Fauvel, C., Coisne, A., Capoulade, R., Bourg, C., Diakov, C., Ribeyrolles, S., Jouan, J., Folliguet, T. A., Kibler, M., Dreyfus, J., et al. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.06.004 · Cited by 8
Sohlman, M., Jauhiainen, R., Vangipurapu, J., Laakso, A., Ala‐Korpela, M., Kuulasmaa, T., & Kuusisto, J. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2419996 · Cited by 7
Prevalence and Prognosis of Aortic Valve Disease in Subjects Older than 85 Years of Age
Leibowitz, D. W., Stessman, J., Jacobs, J. M., Stessman‐Lande, I., & Gilon, D. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.044 · Cited by 7
Transcatheter aortic valve implantation and potential role of 3D imaging
Schoenhagen, P., & Hill, A. J. (2009) · Expert Review of Medical Devices · doi:10.1586/erd.09.18 · Cited by 7
Thomas, J. D., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., Nishimura, A., Otto, C. M., Bonow, R. O., Carabello, B. A., et al. (2014) · Cited by 7
Gałąska, R., Kulawiak‐Gałąska, D., Chmara, M., Chlebus, K., Studniarek, M., Fijałkowski, M., Wasąg, B., Rynkiewicz, A., & Gruchała, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209229 · Cited by 7
Imagen multimodal en la estenosis aórtica: nuevas fronteras diagnósticas y terapéuticas
Ferrer‐Sistach, E., Teis, A., Bayés‐Genís, A., & Delgado, V. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2022.05.023 · Cited by 7
Developmental Pathways in CAVD
Elaine, E., & Katherine, E. (2013) · InTech eBooks · doi:10.5772/54356 · Cited by 8
Whayne, T. F. (2007) · International Journal of Angiology · doi:10.1055/s-0031-1278237 · Cited by 7
Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement
Kalich, B. A., Allender, J. E., & Hollis, I. B. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2056 · Cited by 7
Chen, Z., Shen, Y. H., Xue, Q., Lin, B. W., He, X. Y., Zhang, Y. B., Yang, Y., Shen, W. F., Liu, Y. H., & Yang, K. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.584998 · Cited by 7
Aortic stenosis - pathogenesis, prediction of progression, and percutaneous intervention
Natarajan, D., & Prendergast, B. (2017) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2017.217 · Cited by 7
Pedersen, T. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.028 · Cited by 7
Do bioprosthetic aortic valves deteriorate more rapidly in patients with the metabolic syndrome?
O’Brien, K. D. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0826 · Cited by 7
Role of Statins in Aortic Valve Disease
Rajamannan, N. M. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2006.09.011 · Cited by 7
Statins and Progression of Calcified Aortic Stenosis
Chua, D., & Kalb, K. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h206 · Cited by 7
Do statins slow the progression of aortic valve stenosis?
Tourmousoglou, C. E., Lalos, S., & Psarros, T. K. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2008.178038 · Cited by 7
Yang, L., Xu, M., Gao, X., Liu, J., Zhang, D., Zhang, Z., Ye, Z., Wen, J., & Liu, P. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2508292 · Cited by 6
“However, several randomized controlled trials have indicated that lipid-lowering therapy does not impede the progression of CAVS or reduce adverse aortic valve-related events [50– 52].”
BackgroundTrindade, F., Ferreira, A. F., Saraiva, F. A., Martins, D., Mendes, V. M., Sousa, C., Gavina, C., Leite-Moreira, A. F., Manadas, B. J., Falcão‐Pires, I., et al. (2022) · Proteomes · doi:10.3390/proteomes10030030 · Cited by 6
Delgado‐Lista, J., Mostaza, J. M., Arrobas-Velilla, T., Blanco‐Vaca, F., Masana, L., Pedro‐Botet, J., Pérez‐Martínez, P., Civeira, F., Cuende, J. I., Gómez-Barrado, J. J., et al. (2024) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2024.03.002 · Cited by 6
Statins for the primary prevention of venous thromboembolism
Wang, Z., Zhang, P., Tian, J., Zhang, P., Yang, K., & Li, L. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014769.pub2 · Cited by 6
Guo, Z., Xiong, Z., He, L., Zhang, S., Xu, X., Chen, G., Xie, M., Zhang, W., Hui, Z., Li, J., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02579-x · Cited by 6
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
Moura, L. M., Ramos, S., Kristensen, S. D., Pinto, F. J., Barros, I. M., & Rocha‐Gonçalves, F. (2012) · PubMed · Cited by 6
Treatment of Hypercholesterolemia
Aronow, W. S. (2013) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.s1-006 · Cited by 6
Notenboom, M. L., Hoof, L. V., Schuermans, A., Takkenberg, J. J. M., Rega, F., & Taverne, Y. J. H. J. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11020049 · Cited by 7
Lipid Interventions in Aortic Valvular Disease
Choi, K. J., Tsomidou, C., Lerakis, S., Madanieh, R., Vittorio, T. J., & Kosmas, C. E. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000544 · Cited by 6
Therapeutic effect of statin on aortic stenosis: a review with meta-analysis
Hui, G., Zhang, Q., Wang, B. Y., & He, B. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01137.x · Cited by 6
Rajamannan, N. M. (2013) · InTech eBooks · doi:10.5772/52275 · Cited by 6
Stout, K., & Otto, C. M. (2006) · Medicine · doi:10.1383/medc.2006.34.6.230 · Cited by 6
Relationship between serum adiponectin levels and calcific aortic valve disease
İpek, E. G., Güray, Ü., Guray, Y. A., & Kisacik, H. L. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0035 · Cited by 6
Acuña-Valerio, J., Rodas-Díaz, M. A., Macías-Garrido, E., Posadas‐Sánchez, R., Juárez-Rojas, J. G., Medina-Urrutia, A. X., Cardoso-Saldaña, G. C., Galarza, E. J., Torres‐Tamayo, M., Vargas‐Alarcón, G., et al. (2016) · Archivos de cardiología de México · doi:10.1016/j.acmx.2016.05.013 · Cited by 6
Metadata
- Authors
- Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A.
- Affiliations
- Edinburgh Royal Infirmary (GB)
- University of Edinburgh (GB)
- Borders General Hospital (GB)
- Western General Hospital (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-06-09
- Volume
- 352
- Issue
- 23
- Pages
- 2389-2397
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2117330772
- Cited by
- 1,146
- References
- 41
- Citations by year
- 2026: 46 · 2025: 52 · 2024: 57 · 2023: 37 · 2022: 47 · 2021: 44 · 2020: 59 · 2019: 38 · 2018: 39 · 2017: 52 · 2016: 52 · 2015: 37 · 2014: 65 · 2013: 64 · 2012: 55
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Keywords
- calcific aortic stenosis, atorvastatin, statin therapy, lipid-lowering therapy, valve calcification, disease progression, aortic jet velocity, aortic valve calcium score, LDL cholesterol, hypercholesterolemia, atherosclerosis, echocardiography, CT angiography
- MeSH terms
- Atorvastatin, Anticholesteremic Agents, Aortic Valve, Aortic Valve Stenosis, Blood Flow Velocity, Calcinosis, Double-Blind Method, Heptanoic Acids, Humans, Cholesterol, LDL, Pyrroles, Echocardiography, Doppler, Treatment Failure, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
